Skip to Main Content

Obesity Outpatient – Viking 2745-301

About the Study

For adults living with obesity, or adults who are overweight with at least one comorbidity.

The goal of this study is to demonstrate that VK2735 12.5 mg and/or 17.5 mg QW is superior to placebo for % change in body weight.

This study is sponsored by Viking Therapeutics.

Eligibility

You may be eligible to participate in this study if you:

  • are at least 18 years old

  • have a BMI (Body Mass Index) greater than or equal to 30

  • have a BMI between 27 to 30, and living with at least one weight-related comorbidity (treated or untreated)

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed.

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.